| 51 |
27900576 | Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques. | 2017 Jul |
4 |
| 52 |
27914796 | Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors. | 2017 Jan 15 |
1 |
| 53 |
28338634 | Construction of an Acetylcholinesterase Sensor Based on Synthesized Paramagnetic Nanoparticles, a Simple Tool for Neurotoxic Compounds Assay. | 2017 Mar 24 |
2 |
| 54 |
28374576 | Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase. | 2017 Nov |
3 |
| 55 |
28458525 | Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. | 2017 |
2 |
| 56 |
28711758 | Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies. | 2017 Sep |
1 |
| 57 |
28724799 | Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. | 2017 Jul 20 |
1 |
| 58 |
30023627 | N-Methyl-β-carbolinium Salts and an N-Methylated 8-Oxoisoguanine as Acetylcholinesterase Inhibitors from a Solitary Ascidian, Cnemidocarpa irene. | 2017 Mar 31 |
1 |
| 59 |
30183230 | Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview. | 2017 Feb |
1 |
| 60 |
26588065 | Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. | 2016 Jan 1 |
3 |
| 61 |
26795115 | Ferulic acid-carbazole hybrid compounds: Combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents. | 2016 Feb 15 |
1 |
| 62 |
26833077 | Efficient Synthesis and Discovery of Schiff Bases as Potent Cholinesterase Inhibitors. | 2016 |
1 |
| 63 |
26833890 | Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease. | 2016 Jul |
1 |
| 64 |
27069875 | Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine. | 2016 Jun |
1 |
| 65 |
27222217 | Acetylcholine modulates human working memory and subsequent familiarity based recognition via alpha oscillations. | 2016 Aug 15 |
1 |
| 66 |
27492242 | Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase. | 2016 Jul |
1 |
| 67 |
27505087 | Biological evaluation and docking studies of some benzoxazole derivatives as inhibitors of acetylcholinesterase and butyrylcholinesterase. | 2016 Nov 1 |
1 |
| 68 |
27581632 | Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors. | 2016 |
1 |
| 69 |
27681239 | Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease. | 2016 Nov 15 |
1 |
| 70 |
27793617 | Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell line. | 2016 Dec |
1 |
| 71 |
28635795 | [Current approaches to optimize treatment of dementia and Alzheimer's disease]. | 2016 |
1 |
| 72 |
30549626 | The Biological Activity of Alkaloids from the Amaryllidaceae: From Cholinesterases Inhibition to Anticancer Activity. | 2016 Oct |
1 |
| 73 |
25712639 | A review on Alzheimer's disease pathophysiology and its management: an update. | 2015 Apr |
1 |
| 74 |
25998147 | Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use. | 2015 May 22 |
1 |
| 75 |
26260334 | Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity. | 2015 Sep 1 |
3 |
| 76 |
26264921 | From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease. | 2015 |
2 |
| 77 |
26455564 | Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors. | 2015 |
1 |
| 78 |
27490385 | Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors. | 2015 Jun |
2 |
| 79 |
23307638 | Pharmacological dissociation of novelty responses in the human brain. | 2014 May |
1 |
| 80 |
24694376 | Synthesis and in vitro evaluation of 1,3,4-thiadiazol-2-yl urea derivatives as novel AChE inhibitors. | 2014 |
1 |
| 81 |
24774720 | Rapid detoxification of benzodiazepine or Z-drugs dependence using acetylcholinesterase inhibitors. | 2014 Jul |
1 |
| 82 |
24852273 | New developments in redox chemical delivery systems by means of 1,4-dihydroquinoline-based targetor: application to galantamine delivery to the brain. | 2014 Jun 23 |
1 |
| 83 |
25202788 | [Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases]. | 2014 |
1 |
| 84 |
25462993 | Ionic liquid mediated synthesis and molecular docking study of novel aromatic embedded Schiff bases as potent cholinesterase inhibitors. | 2014 Dec |
1 |
| 85 |
22391555 | Acetylcholinesterase capillary enzyme reactor for screening and characterization of selective inhibitors. | 2013 Jan 25 |
1 |
| 86 |
22931533 | Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease. | 2013 Mar |
3 |
| 87 |
23229229 | In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile. | 2013 Mar |
1 |
| 88 |
23330848 | Acetylcholinesterase immobilized capillary reactors-tandem mass spectrometry: an on-flow tool for ligand screening. | 2013 Mar 14 |
1 |
| 89 |
23408070 | Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease. | 2013 Apr |
3 |
| 90 |
23602518 | Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives. | 2013 Jun 1 |
1 |
| 91 |
23618168 | New approach for the potentiometric-enzymatic assay of reversible-competitive enzyme inhibitors. Application to acetylcholinesterase inhibitor galantamine and its determination in pharmaceuticals and human urine. | 2013 Jun 15 |
2 |
| 92 |
23782591 | Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial. | 2013 May 4 |
1 |
| 93 |
24081314 | Drugs for cognitive loss and dementia. | 2013 Oct |
1 |
| 94 |
24092978 | Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease. | 2013 |
1 |
| 95 |
22211487 | Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities. | 2012 Jun |
2 |
| 96 |
22539182 | Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand. | 2012 Jun 14 |
1 |
| 97 |
22972560 | Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry. | 2012 Oct |
3 |
| 98 |
23033965 | Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease. | 2012 Nov 26 |
2 |
| 99 |
23085657 | A novel class of selective acetylcholinesterase inhibitors: synthesis and evaluation of (E)-2-(benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles. | 2012 Oct 15 |
1 |
| 100 |
23233806 | Galantamine versus donepezil in Chinese patients with Alzheimer's disease: results from a randomized, double-blind study. | 2012 |
1 |